6.79
4.77%
-0.34
Mind Medicine Inc 주식(MNMD)의 최신 뉴스
HC Wainwright Reiterates "Buy" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat
Leerink Partnrs Has Bearish Outlook for MNMD Q4 Earnings - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Equities Analysts Set Expectations for MNMD Q1 Earnings - Defense World
MindMed Initiates Second Phase 3 Study of MM120 for Anxiety - TipRanks
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpHere's Why - MarketBeat
What is Leerink Partnrs' Forecast for MNMD Q1 Earnings? - MarketBeat
MindMed launches phase 3 trial for anxiety treatment - Investing.com
MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder - StreetInsider.com
Mindmed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of Mm120 in Generalized Anxiety Disorder - Marketscreener.com
(MNMD) Trading Signals - Stock Traders Daily
MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call (MNMD) - Seeking Alpha
Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish - MSN
Mind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Evercore ISI - MarketBeat
Evercore ISI Group Initiates Coverage of Mind Medicine (MNMD) with Outperform Recommendation - MSN
Mind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated by Analysts at Evercore ISI - MarketBeat
This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
Why Mind Medicine Stock Is Soaring Today - MSN
Where are the Opportunities in (MNMD) - Stock Traders Daily
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.4%What's Next? - MarketBeat
Wealth Enhancement Advisory Services LLC Acquires 2,230 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Barclays PLC Has $775,000 Stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat
MindMed gives more detail to investors in latest presentation - Green Market Report
Psychedelic drug developer Lykos could get lifeline from former Tesla board member - Seeking Alpha
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Mind Medicine Inc Reports Topline Data from Phase 1 Trial of MM-110 in Development for Treatment of Opioid Withdrawal - Marketscreener.com
Institutional investors are Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) biggest bettors and were rewarded after last week's US$73m market cap gain - Simply Wall St
MindMed (MNMD) Stock Surges on Psychedelic Mushroom Developments - GuruFocus.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 7.8% HigherShould You Buy? - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.7%Should You Sell? - MarketBeat
MindMed to Participate in the Jefferies Global Healthcare Conference - Marketscreener.com
Geode Capital Management LLC Has $9.55 Million Stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Purchased by Barclays PLC - MarketBeat
(MNMD) Investment Analysis - Stock Traders Daily
Mind Medicine's chief medical officer sells shares worth $49,357 - Investing.com India
Mind Medicine's chief medical officer sells shares worth $49,357 By Investing.com - Investing.com Australia
Mind Medicine CEO Robert Barrow sells shares worth $141,957 By Investing.com - Investing.com Nigeria
Mind Medicine's chief legal officer sells $33,576 in stock - Investing.com India
Mind Medicine CEO Robert Barrow sells shares worth $141,957 - Investing.com India
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) CEO Sells $141,957.58 in Stock - MarketBeat
Carrie Liao Sells 2,273 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Stock - MarketBeat
Mind medicine's chief accounting officer sells shares for $16,888 By Investing.com - Investing.com Canada
Mind Medicine’s chief medical officer sells shares worth $49,357 By Investing.com - Investing.com Nigeria
Mind Medicine's chief legal officer sells $33,576 in stock By Investing.com - Investing.com South Africa
Mind Medicine’s chief legal officer sells $33,576 in stock By Investing.com - Investing.com Nigeria
자본화:
|
볼륨(24시간):